首页> 美国卫生研究院文献>PLoS Clinical Trials >How to Estimate the Cost of Point-of-Care CD4 Testing in Program Settings: An Example Using the Alere Pima™ Analyzer in South Africa
【2h】

How to Estimate the Cost of Point-of-Care CD4 Testing in Program Settings: An Example Using the Alere Pima™ Analyzer in South Africa

机译:如何在程序设置中估算即时医疗CD4测试的成本:以南非Alere Pima™分析仪为例

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Integrating POC CD4 testing technologies into HIV counseling and testing (HCT) programs may improve post-HIV testing linkage to care and treatment. As evaluations of these technologies in program settings continue, estimates of the costs of POC CD4 tests to the service provider will be needed and estimates have begun to be reported. Without a consistent and transparent methodology, estimates of the cost per CD4 test using POC technologies are likely to be difficult to compare and may lead to erroneous conclusions about costs and cost-effectiveness. This paper provides a step-by-step approach for estimating the cost per CD4 test from a provider's perspective. As an example, the approach is applied to one specific POC technology, the Pima™ Analyzer. The costing approach is illustrated with data from a mobile HCT program in Gauteng Province of South Africa. For this program, the cost per test in 2010 was estimated at $23.76 (material costs = $8.70; labor cost per test = $7.33; and equipment, insurance, and daily quality control = $7.72). Labor and equipment costs can vary widely depending on how the program operates and the number of CD4 tests completed over time. Additional costs not included in the above analysis, for on-going training, supervision, and quality control, are likely to increase further the cost per test. The main contribution of this paper is to outline a methodology for estimating the costs of incorporating POC CD4 testing technologies into an HCT program. The details of the program setting matter significantly for the cost estimate, so that such details should be clearly documented to improve the consistency, transparency, and comparability of cost estimates.
机译:将POC CD4检测技术整合到HIV咨询和检测(HCT)计划中,可以改善HIV检测后与护理和治疗之间的联系。随着程序设置中对这些技术的评估的不断进行,将需要对服务提供商进行POC CD4测试成本的估算,并且已经开始报告估算。如果没有一致和透明的方法,使用POC技术对每个CD4测试的成本估算可能很难进行比较,并且可能得出关于成本和成本效益的错误结论。本文提供了一种分步方法,从提供商的角度估计每个CD4测试的成本。例如,该方法应用于一种特定的POC技术,即Pima™分析仪。南非豪登省移动HCT计划的数据说明了成本核算方法。对于此计划,2010年每次测试的成本估计为23.76美元(材料成本== 8.70美元;每次测试的人工成本== 7.33美元;设备,保险和日常质量控制= 7.72美元)。人工和设备成本的差异很大,这取决于程序的运行方式以及一段时间内完成的CD4测试次数。上述分析中未包括的,持续的培训,监督和质量控制方面的额外费用可能会进一步增加每次测试的费用。本文的主要贡献在于概述一种估算将POC CD4测试技术纳入HCT计划的成本的方法。计划设置的细节对于成本估算至关重要,因此应清楚记录这些细节,以提高成本估算的一致性,透明度和可比性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号